Crescent Biopharma (CBIO) Free Cash Flow (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.19% |
| Dec 31, 2025 | -43.78% |
| Sep 30, 2025 | -8.98% |
| Jun 30, 2025 | -52.88% |
| Mar 31, 2025 | -73.09% |
| Jun 30, 2024 | 15.41% |
| Mar 31, 2024 | -38.08% |
| Dec 31, 2023 | 12.37% |
| Sep 30, 2023 | -24.42% |
| Jun 30, 2023 | 39.83% |
| Mar 31, 2023 | -46.74% |
| Dec 31, 2022 | 8.21% |
| Sep 30, 2022 | 47.03% |
| Jun 30, 2022 | -18.44% |
| Mar 31, 2022 | -7.26% |
| Dec 31, 2021 | 24.43% |
| Sep 30, 2021 | -24.49% |
| Jun 30, 2021 | 3.62% |
| Mar 31, 2021 | -45.00% |
| Dec 31, 2020 | 15.27% |
| Sep 30, 2020 | 21.01% |
| Jun 30, 2020 | -314.97% |
| Mar 31, 2020 | 72.60% |
| Dec 31, 2019 | 4.92% |
| Sep 30, 2019 | -17.42% |
| Jun 30, 2019 | 20.28% |
| Mar 31, 2019 | -43.34% |
| Dec 31, 2018 | 0.73% |
| Sep 30, 2018 | 22.72% |
| Jun 30, 2018 | -27.95% |
| Mar 31, 2018 | -21.69% |
| Dec 31, 2017 | -34.18% |
| Sep 30, 2017 | 0.15% |
| Jun 30, 2017 | 31.26% |
| Mar 31, 2017 | -37.64% |
| Dec 31, 2016 | 11.15% |
| Sep 30, 2016 | -5.12% |
| Jun 30, 2016 | 23.24% |
| Mar 31, 2016 | -32.85% |
| Dec 31, 2015 | -151.54% |
| Sep 30, 2015 | 312.76% |
| Jun 30, 2015 | 27.10% |
| Mar 31, 2015 | -41.14% |
| Dec 31, 2014 | -27.06% |
| Sep 30, 2014 | -153.17% |
| Jun 30, 2014 | 451.09% |
| Mar 31, 2014 | 53.37% |
| Dec 31, 2013 | -62.70% |
| Sep 30, 2013 | -25.53% |
| Jun 30, 2013 | 29.67% |